top of page
Browse by category
Search
One in seven Medicare beneficiaries with high BMI and established CVD may qualify for OMMs adding $34 billion to costs
Current federal regulation restricts Medicare from covering obesity management medications (OMMs) prescribed solely for weight loss....
Semaglutide’s cardiac benefits extend to people with heart failure
The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events (MACE) among people...
Sharp rise in the numbers young Chinese people diagnosed with obesity-related cancers
Obesity-related cancer rates in China were rising at an alarming 3.6% every year between 2007 and 2021, while non-obesity-related cancers...
Titan SGS stapler results in shorter length of hospital stay, fewer readmissions, reduced post-operative nausea/vomiting events and operative times
Patients undergoing laparoscopic sleeve gastrectomy (LSG) using the latest Titan SGS single-fire stapler (developed by Standard...
Tirzepatide reduced the risk of developing T2Dm by 94% in adults with pre-diabetes and obesity or overweight
Eli Lilly and Company has announced positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating...
Strong relationship between the increase in metabolic activity caused by once-daily GLP-1 and the amount of weight lost
A study carried out in St Vincent's University Hospital (SVUH) Dublin, Ireland, challenges the belief that weight-loss medications such...
Browse by tag
bottom of page